Affiliation: The Salk Institute
- Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's diseaseGustavo Dziewczapolski
Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA
J Neurosci 29:8805-15. 2009..These results are consistent with the hypothesis that the alpha7nAChR plays a role in AD and suggest that interrupting alpha7nAChR function could be beneficial in the treatment of AD...
- Metformin treatment alters memory function in a mouse model of Alzheimer's diseaseKacee A DiTacchio
The Salk Institute for Biological Studies, Molecular Neurobiology Laboratory, La Jolla, CA, USA
J Alzheimers Dis 44:43-8. 2015....
- Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic lossMaria Talantova
Del E Webb Center for Neuroscience, Aging, and Stem Cell Research, Sanford Burnham Medical Research Institute, La Jolla, CA 92037, USA
Proc Natl Acad Sci U S A 110:E2518-27. 2013..Importantly, the improved NMDAR antagonist NitroMemantine, which selectively inhibits extrasynaptic over physiological synaptic NMDAR activity, protects synapses from Aβ-induced damage both in vitro and in vivo. ..